Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-09 11:12 am Purchase | 13G | Cassava Sciences, Inc. SAVA | VANGUARD GROUP INC | 2,196,925 5.27% | 136,106 (+6.60%) | View |
| 2023-02-08 4:43 pm Purchase | 13G | Cassava Sciences, Inc. SAVA | CASSAVA SCIENCES INC SAVA | 2,021,414 4.7% | 282,908 (+16.27%) | View |
| 2023-02-01 4:54 pm Sale | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 2,564,528 6.1% | -196,450 (-7.12%) | View |
| 2022-02-09 3:33 pm Purchase | 13G | Cassava Sciences, Inc. SAVA | VANGUARD GROUP INC | 2,060,819 5.15% | 2,060,819 (New Position) | View |
| 2022-02-03 5:05 pm Purchase | 13G | Cassava Sciences, Inc. SAVA | BARBIER REMI | 2,065,987 5% | 50,205 (+2.49%) | View |
| 2022-02-02 7:11 pm Purchase | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 2,760,978 6.9% | 790,209 (+40.10%) | View |
| 2021-02-16 09:48 am Sale | 13G | Cassava Sciences, Inc. SAVA | CVI Investments Inc. | 0 0% | -2,000,000 (Position Closed) | View |
| 2021-02-16 08:03 am Purchase | 13G | Cassava Sciences, Inc. SAVA | BARBIER REMI | 2,015,782 5.6% | 91,535 (+4.76%) | View |
| 2021-02-11 5:08 pm Sale | 13G | Cassava Sciences, Inc. SAVA | SATTERFIELD THOMAS A JR | 450,000 1.8% | -873,195 (-65.99%) | View |
| 2021-02-10 8:02 pm Sale | 13G | Cassava Sciences, Inc. SAVA | RENAISSANCE TECHNOLOGIES LLC | 0 0% | -1,015,759 (Position Closed) | View |
| 2021-02-10 3:36 pm Sale | 13G | Cassava Sciences, Inc. SAVA | Hudson Bay Capital Management LP | 0 0% | -1,176,471 (Position Closed) | View |
| 2021-02-05 5:01 pm Unchanged | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 1,970,769 5.6% | 0 (Unchanged) | View |
| 2021-02-02 3:13 pm Purchase | 13G | Cassava Sciences, Inc. SAVA | BlackRock Inc. BLK | 1,970,769 5.6% | 548,929 (+38.61%) | View |
| 2020-11-23 10:04 am Purchase | 13G | Cassava Sciences, Inc. SAVA | CVI Investments Inc. | 2,000,000 5.7% | 1,095,629 (+121.15%) | View |
| 2020-10-23 8:16 pm Sale | 13G | Cassava Sciences, Inc. SAVA | Bleichroeder LP | 784,314 3.1% | -955,226 (-54.91%) | View |
| 2020-02-14 3:23 pm Sale | 13G | Cassava Sciences, Inc. SAVA | ARMISTICE CAPITAL LLC | 0 0% | -1,911,130 (Position Closed) | View |
| 2020-02-13 06:02 am Sale | 13G | Cassava Sciences, Inc. SAVA | SATTERFIELD THOMAS A JR | 1,323,195 7.4% | -50,000 (-3.64%) | View |
| 2020-02-12 4:01 pm Sale | 13G | Cassava Sciences, Inc. SAVA | Bleichroeder LP | 1,739,540 10.1% | -694,291 (-28.53%) | View |
| 2020-02-12 12:07 pm Purchase | 13G | Cassava Sciences, Inc. SAVA | RENAISSANCE TECHNOLOGIES LLC | 1,015,759 5.9% | 1,015,759 (New Position) | View |
| 2020-02-11 07:00 am Sale | 13G | Cassava Sciences, Inc. SAVA | UBS Group AG | 0 0% | -2,186,540 (Position Closed) | View |